Psoriasis affects 2-3% of the world’s population and in the United States, between 5.8 and 7.5 million people are affected. Up to thirty percent of patients with Psoriasis also develop Psoriatic Arthritis. This activity reviews the impact of these conditions on patients’ quality of life, the underlying systemic inflammation, and the relationship to the metabolic syndrome. Various management strategies and novel therapeutic options in the treatment of Psoriasis are discussed in detail.
This webcast was recorded live and is being used with the permission of the presenter
- Define strategies for early recognition and diagnosis of psoriasis and psoriatic arthritis (PsA)
- Recognize the impact of psoriasis and PsA, including their effect on mood, cardiovascular risk, and quality of life
- Evaluate various management options for psoriasis and PsA, and institute appropriate initial treatment
- Identify novel therapeutic options for psoriasis management
- Implement treatment plans for patients who are candidates for systemic and biologic therapy
|
Credits
|
Type
|
Accreditation Statement
|
Designation Statement
|
|
1.00
|
AMA PRA Category 1 Credit(s)TM
|
The National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
|
The National Association for Continuing Education designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
|
Faculty:
Robert G. Greenberg, MD
Director of The East Bay Psoriasis Treatment Center
San Ramon, California
Disclosures:
Robert G. Greenberg, MD, Speaker, is a speaker for Amgen, Abbott, Centocor, Galderma, and Leo; is on the advisory boards for Galderma and Leo.
Gregg Sherman, MD, Course Director, has no relationships to disclose.
Michelle Frisch, MPH, Activity Planning Committee, has no relationships to disclose.
Alan Goodstat, LCSW, Activity Planning Committee, has no relationships to disclose.
Harvey Parker, PhD, Activity Planning Committee, has no relationships to disclose.
Brad Glick, DO, MPH, Activity Planning Commitee, serves as a speaker for Stiefel, Galderma, Abbott, Amgen, Warner Chilcott (Leo), Graceway.
None of the peer reviewers have any relevant financial relationships to disclose.
Accredited Provider:
National Association for Continuing Education
Commercial Supporter:
Abbott Laboratories Inc. provided commercial support for this enduring activity.
Instructions:
To obtain credit, a score of 60% or better is required. This CE is offered at no cost to participants. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the post-test, and received your digital copy of your credit certificate. Your online certificate will be saved on myCME.com within your Profile/Exam History, which you can then access at any time.
SYSTEM REQUIREMENTS:
WINDOWS PC SYSTEM REQUIREMENTS:
266-MHz Pentium II; Windows 98 or higher; 64 MB RAM; 800 x 600 screen resolution
set for “High Color (16-Bit)”; Macromedia Flash Player 6 or higher.
MACINTOSH® SYSTEM REQUIREMENTS:
Power Mac g3 at 300 MHz; System 8.5 or higher (excluding Mac OSX); 96 MB RAM; 20
MB minimum hard disk space available; 800 x 600 screen resolution set to “Thousands
of Colors”; Macromedia Flash Player 6 or higher.